Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Peijia Medical Raises $302 Million in Hong Kong IPO for Medical Devices

Nanjing Legend Approved for $100 Million US IPO on NASDAQ

Ocumension Files for Hong Kong IPO to Advance Ophthalmology Portfolio

AkesoBio Completes $335 Million Hong Kong IPO; Climbs 50% on First Trading Day

Junshi Biosciences Approved for Shanghai STAR IPO, a Dual Listing with Hong Kong

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China